1. The role of oncology in the context to gender medicine

   • M. Hochleitner

   Editorial 03 January 2012 Pages: 205 - 207

2. Gender aspects in haematology and oncology: Overview and own observations in lung cancer

   • M. Fiegl
   • C. Thöni
   • M. Hochleitner

   Leading article 03 January 2012 Pages: 209 - 216

3. Preclinical research in oncology: Gender aspects

   • C. Thöni

   Short review 03 January 2012 Pages: 217 - 220

4. Gender aspects in tumours of the nervous system

   • C. Marosi

   Short review 03 January 2012 Pages: 221 - 223

5. Gender differences in quality of life in patients with haematological malignancies

   • M. Sztankay
   • J. Giesinger
   • B. Holzner

   Short review 03 January 2012 Pages: 224 - 226

6. Gender and haemato-oncology: Aspects of pharmacokinetics and pharmacodynamics

   • R. M. Mader
   • M. Fiegl

   Short review 03 January 2012 Pages: 227 - 231

7. Cancer in the elderly and gender aspects – situation in Tyrol

   • S. Geiger-Gritsch
   • H. Mühlböck
   • W. Oberaigner

   Short review 03 January 2012 Pages: 232 - 235

8. Gender and oncology: Pathological observations

   • W. Sterlacci
   • R. Stockinger
   • M. Fiegl

   Short review 03 January 2012 Pages: 236 - 240

9. Molecular oncology in lung cancer – between biomarkers and clinical application. Relevance of the Ras–Raf–MEK–ERK pathway

   • W. Berger
   • A. Pircher
   • W. Hilbe

   Review 03 January 2012 Pages: 242 - 247

10. A histology-based algorithm in the molecular diagnosis of mutations of the epidermal growth factor receptor (EGFR)–in non-small-cell lung cancer (NSCLC)^*

    • H. Popper
    • F. Wrba
    • Pulmonary Pathology Working Group of the Austrian Society of Pathology/International Academy of Pathology

    Consensus report 03 January 2012 Pages: 248 - 253

11. Surgical topics of interest at the 14th World Conference on Lung Cancer

    • F. Augustin
    • J. Bodner

    Congress report 03 January 2012 Pages: 254 - 255

12. Epidermal growth factor receptor-targeted treatment strategies in advanced pancreatic cancer: Is K-RAS mutational testing ready for prime time?

    • T. Bauernhofer

    Controversy 03 January 2012 Pages: 257 - 259

13. The role of radiochemotherapy in the multimodal treatment of pancreatic ductal adenocarcinoma: Standard procedure or individual decision?

    • R. Jäger
    • A. de Vries

    Short review 03 January 2012 Pages: 260 - 264

14. Treatment of invasive aspergillosis in cancer patients

    • J. Auberger
    • G. Russ
    • A. Egle

    Short review 03 January 2012 Pages: 266 - 272